Canada House Cannabis Group Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHV.CN research report →
Companywww.canadahouse.ca
Canada House Cannabis Group Inc. , through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics.
- CEO
- Michael Perron CPA,
- IPO
- 2023
- Employees
- 127
- HQ
- Pickering, ON, CA
Valuation
- Market Cap
- $1.62M
- P/E
- -0.68
- P/S
- 0.07
- P/B
- 0.98
- EV/EBITDA
- 7.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 32.15%
- Op Margin
- -4.86%
- Net Margin
- -9.01%
- ROE
- -52.60%
- ROIC
- -4.34%
Growth & Income
- Revenue
- $24.57M · 0.00%
- Net Income
- $-2,213,000 · 0.00%
- EPS
- $-0.05 · 0.00%
- Op Income
- $-1,193,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $1.05
- 52W Low
- $0.03
- 50D MA
- $1.05
- 200D MA
- $1.05
- Beta
- -0.50
- Avg Volume
- 0
Get TickerSpark's AI analysis on CHV.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CHV.CN Coverage
We haven't published any research on CHV.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CHV.CN Report →